Advanced Materials,
Год журнала:
2024,
Номер
36(15)
Опубликована: Янв. 17, 2024
Abstract
Currently,
certain
cancer
patients
exhibit
resistance
to
radiotherapy
due
reduced
DNA
damage
under
hypoxic
conditions
and
acquired
immune
tolerance
triggered
by
transforming
growth
factor‐β1
(TGF‐β1)
membrane‐localized
programmed
death
ligand‐1
(PD‐L1).
Meanwhile,
cytoplasm‐distributed
PD‐L1
induces
through
accelerating
repair
(DDR).
However,
the
disability
of
clinically
used
antibodies
in
inhibiting
limits
their
effectiveness.
Therefore,
a
nanoadjuvant
is
developed
sensitize
via
multi‐level
immunity
activation
depressing
TGF‐β1
triphenylphosphine‐derived
metformin,
activating
cGAS‐STING
pathway
generating
Mn
2+
from
MnO
2
producing
more
dsDNA
reversing
tumor
hypoxia
impairing
DDR.
Thus,
Tpp‐Met@MnO
@Alb
effectively
enhances
efficiency
inhibit
progression
irradiated
local
abscopal
tumors
lung
metastases,
offering
long‐term
memory
antitumor
without
discernible
side
effects.
Overall,
has
potential
be
applied
for
overcoming
radio‐immunotherapy
resistance.
Advanced Materials,
Год журнала:
2022,
Номер
35(19)
Опубликована: Сен. 19, 2022
Abstract
As
an
essential
micronutrient,
manganese
(Mn)
participates
in
various
physiological
processes
and
plays
important
roles
host
immune
system,
hematopoiesis,
endocrine
function,
oxidative
stress
regulation.
Mn‐based
nanoparticles
are
considered
to
be
biocompatible
show
versatile
applications
nanomedicine,
particular
utilized
tumor
immunotherapy
the
following
ways:
1)
acting
as
a
nanocarrier
deliver
immunotherapeutic
agents
for
immunotherapy;
2)
serving
adjuvant
regulate
microenvironment
enhance
3)
activating
host's
system
through
cGAS‐STING
pathway
trigger
4)
real‐time
monitoring
effect
by
magnetic
resonance
imaging
(MRI)
since
Mn
2+
ions
ideal
MRI
contrast
agent
which
can
significantly
T
1
‐weighted
signal
after
binding
proteins.
This
comprehensive
review
focuses
on
most
recent
progress
of
nanoplatforms
immunotherapy.
The
characteristics
first
discussed
guide
design
multifunctional
nanoplatforms.
Then
biomedical
nanoplatforms,
including
alone,
immunotherapy‐involved
multimodal
synergistic
therapy,
imaging‐guided
detail.
Finally,
challenges
future
developments
highlighted.
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Май 23, 2023
The
immunologically
"cold"
microenvironment
of
triple
negative
breast
cancer
results
in
resistance
to
current
immunotherapy.
Here,
we
reveal
the
immunoadjuvant
property
gas
therapy
with
cyclic
GMP-AMP
synthase-stimulator
interferon
genes
(cGAS-STING)
pathway
activation
augment
aggregation-induced
emission
(AIE)-active
luminogen
(AIEgen)-based
photoimmunotherapy.
A
virus-mimicking
hollow
mesoporous
tetrasulfide-doped
organosilica
is
developed
for
co-encapsulation
AIEgen
and
manganese
carbonyl
fabricate
nanoadjuvant.
As
tetra-sulfide
bonds
are
responsive
intratumoral
glutathione,
nanoadjuvant
achieves
tumor-specific
drug
release,
promotes
photodynamic
therapy,
produces
hydrogen
sulfide
(H2S).
Upon
near-infrared
laser
irradiation,
AIEgen-mediated
phototherapy
triggers
burst
carbon
monoxide
(CO)/Mn2+.
Both
H2S
CO
can
destroy
mitochondrial
integrity
induce
leakage
DNA
into
cytoplasm,
serving
as
immunoadjuvants
activate
cGAS-STING
pathway.
Meanwhile,
Mn2+
sensitize
cGAS
STING-mediated
type
I
production.
Consequently,
potentiates
photoimmunotherapy
poorly
immunogenic
tumors
female
mice.
Chemical Society Reviews,
Год журнала:
2023,
Номер
52(6), С. 2031 - 2081
Опубликована: Янв. 1, 2023
Bioactive
materials
are
a
special
class
of
biomaterials
that
can
react
in
vivo
to
induce
biological
response
or
regulate
functions,
thus
achieving
better
curative
effect
than
traditional
inert
biomaterials.
For
cancer
theranostics,
compared
with
organic
polymer
nanomaterials,
inorganic
nanomaterials
possess
unique
physical
and
chemical
properties,
have
stronger
mechanical
stability
on
the
basis
maintaining
certain
bioactivity,
easy
be
compounded
various
carriers
(polymer
carriers,
etc.),
so
as
achieve
specific
antitumor
efficacy.
After
entering
nanoscale,
due
nano-size
effect,
high
surface
area
nanostructures,
exhibit
effects,
which
significantly
influence
interaction
organisms.
Therefore,
research
applications
bioactive
theranostics
attracted
wide
attention.
In
this
review,
we
mainly
summarize
recent
progress
also
introduce
definition,
synthesis
modification
strategies
nanomaterials.
Thereafter,
tumor
imaging
therapy,
including
microenvironment
(TME)
regulation,
catalytic
gas
regulatory
cell
death
immunotherapy,
discussed.
Finally,
biosafety
challenges
mentioned,
their
future
development
opportunities
prospected.
This
review
highlights
bioapplication
Abstract
Metal‐based
nanomaterials
have
attracted
broad
attention
recently
due
to
their
unique
biological
physical
and
chemical
properties
after
entering
tumor
cells,
namely
effects.
In
particular,
the
abilities
of
Ca
2+
modulate
T
cell
receptors
activation,
K
+
regulate
stem
differentiation,
Mn
activate
STING
pathway,
Fe
2+/3+
induce
ferroptosis
enhance
catalytic
therapy,
make
metal
ions
metal‐based
play
crucial
roles
in
cancer
treatments.
Therefore,
superior
advantages
characteristics
microenvironment,
we
will
summarize
recent
progress
anti‐tumor
effects
nanomaterials.
Based
on
different
this
review
mainly
focuses
following
five
aspects:
(1)
metal‐enhanced
radiotherapy
sensitization,
(2)
(3)
ferroptosis,
(4)
pyroptosis,
(5)
immunotherapy.
At
same
time,
shortcomings
therapy
are
also
discussed,
future
research
directions
been
prospected.
The
highlights
promising
biosafety,
potent
efficacy
for
in‐depth
various
mechanism
studies
provide
novel
ideas
application
ACS Nano,
Год журнала:
2023,
Номер
17(5), С. 4495 - 4506
Опубликована: Фев. 27, 2023
Radiotherapy
(RT),
as
one
of
the
main
methods
in
clinical
treatment
various
malignant
tumors,
would
induce
systemic
immunotherapeutic
effects
by
triggering
immunogenic
cell
death
(ICD)
cancer
cells.
However,
antitumor
immune
responses
produced
RT-induced
ICD
alone
usually
are
not
robust
enough
to
eliminate
distant
tumors
and
thus
ineffective
against
metastases.
Herein,
a
biomimetic
mineralization
method
for
facile
synthesis
MnO2
nanoparticles
with
high
anti-programmed
ligand
1
(αPDL1)
encapsulation
efficiency
(αPDL1@MnO2)
is
proposed
reinforce
responses.
This
therapeutic
nanoplatforms-mediated
RT
can
significantly
improve
killing
tumor
cells
effectively
evoke
overcoming
hypoxia-induced
radio-resistance
reprogramming
immunosuppressive
microenvironment
(TME).
Furthermore,
released
Mn2+
ions
from
αPDL1@MnO2
under
acidic
pH
activate
cyclic
GMP-AMP
synthase
(cGAS)-stimulator
interferon
genes
(STING)
pathway
facilitate
dendritic
(DCs)
maturation.
Meanwhile,
αPDL1
further
promote
intratumoral
infiltration
cytotoxic
T
lymphocytes
(CTLs)
trigger
responses,
resulting
strong
abscopal
effect
inhibit
Overall,
biomineralized
MnO2-based
nanoplatforms
offer
simple
strategy
TME
modulation
activation,
which
promising
enhanced
immunotherapy.
Advanced Materials,
Год журнала:
2022,
Номер
35(21)
Опубликована: Дек. 16, 2022
Radiotherapy
(RT)
uses
ionizing
radiation
to
eradicate
localized
tumors
and,
in
rare
cases,
control
outside
of
the
irradiated
fields
via
stimulating
an
antitumor
immune
response
(abscopal
effect).
However,
therapeutic
effect
RT
is
often
limited
by
inherent
physiological
barriers
tumor
microenvironment
(TME),
such
as
hypoxia,
abnormal
vasculature,
dense
extracellular
matrix
(ECM),
and
immunosuppressive
TME.
Thus,
it
critical
develop
new
strategies
that
can
remodel
TME
overcome
radio-resistance
suppression.
In
past
decade,
high-Z-element
nanoparticles
have
been
developed
increase
radiotherapeutic
indices
reducing
X-ray
doses
side
effects
normal
tissues
enhance
abscopal
activating
elicit
systemic
immunity.
this
review,
principles
radiosensitization,
mechanisms
suppression,
use
various
sensitize
TMEs
for
enhanced
efficacy
are
discussed.
The
challenges
clinical
translation
multifunctional
TME-remodeling
nanoradiosensitizers
also
highlighted.
ACS Nano,
Год журнала:
2022,
Номер
16(10), С. 16909 - 16923
Опубликована: Окт. 6, 2022
Cancer
immunotherapy
holds
great
promise
but
is
generally
limited
by
insufficient
induction
of
anticancer
immune
responses.
Here,
a
metal
micellar
nanovaccine
developed
the
self-assembly
manganese
(Mn),
stimulator
interferon
genes
(STING)
agonist
(ABZI)
and
naphthalocyanine
(ONc)
coordinated
nanoparticles
(ONc-Mn-A)
in
maleimide-modified
Pluronic
F127
(malF127)
micelles.
Owing
to
synergy
between
Mn
ABZI,
nanovaccine,
termed
ONc-Mn-A-malF127,
elevates
levels
interferon-β
(IFNβ)
324-
8-fold
vivo,
compared
use
or
ABZI
alone.
As
such,
activation
cyclic
guanosine
monophosphate-adenosine
monophosphate
synthase
(cGAS)-STING
pathway
induces
sufficient
dendritic
cell
(DC)
maturation,
eventually
resulting
death
CD8+
T
cell-sensitive
tumors
cell-resistant
simultaneously
promoting
cytotoxic
cells
NK
cells,
respectively.
Furthermore,
with
ONc
used
as
chelator
an
efficient
photosensitizer,
photoinduced
immunogenic
(ICD)
tumor
releases
damage-associated
molecular
patterns
(DAMPs)
neoantigens
from
dying
primary
upon
laser
irradiation,
which
are
captured
situ
malF127
then
transported
DCs.
After
treatment,
addition
photothermal
therapy,
responses
characterized
level
IFNβ
further
elevated
another
4-fold.
In
murine
cancer
models,
ICD-based
metalloimmunotherapy
using
ONc-Mn-A-malF127
single
dose
intravenous
injection
achieved
eradication
distant
tumors.
Taken
together,
offers
nanoplatform
enhance
efficacy
ICD
based
strong
abscopal
effect.
Journal of the American Chemical Society,
Год журнала:
2023,
Номер
145(10), С. 5803 - 5815
Опубликована: Фев. 27, 2023
The
antioxidant
system,
signed
with
reduced
glutathione
(GSH)
overexpression,
is
the
key
weapon
for
tumor
to
resist
attack
by
reactive
oxygen
species
(ROS).
Counteracting
ROS
depletion
GSH
an
effective
strategy
guarantee
antitumor
efficacy
of
nanocatalytic
therapy.
However,
simply
reducing
concentration
does
not
sufficiently
improve
response
therapy
intervention.
Herein,
a
well-dispersed
MnOOH
nanocatalyst
developed
catalyze
autoxidation
and
peroxidase-like
reaction
concurrently
respectively
promote
H2O2
decomposition
produce
abundant
such
as
hydroxyl
radical
(·OH),
thereby
generating
highly
superadditive
catalytic
therapeutic
efficacy.
Such
that
transforms
endogenous
"antioxidant"
into
"oxidant"
may
open
new
avenue
development
medicine.
Moreover,
released
Mn2+
can
activate
sensitize
cGAS-STING
pathway
damaged
intratumoral
DNA
double-strands
induced
produced
further
macrophage
maturation
M1-polarization,
which
will
boost
innate
immunotherapeutic
Resultantly,
simple
medicine
capable
simultaneously
catalyzing
generation,
mediating
immune
activation,
holds
great
potential
in
treatment
malignant
tumors.